# Almaden Minerals Ltd: financial statements, quarterly

AAUAF · OTC · CIK 1015647 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aauaf.md) · [Financials](/companies/aauaf/financials.md) · [Filings](/companies/aauaf/filings.md) · [Insiders](/companies/aauaf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aauaf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [5.8](/filings/0001171843-22-002985.md) | [3.7](/filings/0001171843-23-002634.md) | [2.3](/filings/0001171843-24-002288.md) | [2.3](/filings/0001171843-25-002591.md) | [5.8](/filings/0001171843-26-001802.md) |
| Current assets | $m | not reported | not reported | [10.2](/filings/0001171843-18-002347.md) | [16.7](/filings/0001171843-19-001741.md) | [5.5](/filings/0001171843-20-002057.md) | [2.6](/filings/0001171843-21-002114.md) | [3.7](/filings/0001171843-22-002985.md) | [11.2](/filings/0001171843-23-002634.md) | [7.9](/filings/0001171843-24-002288.md) | [5.8](/filings/0001171843-25-002591.md) | [4.9](/filings/0001171843-26-001802.md) | [6.5](/filings/0001171843-26-001802.md) |
| Total assets | $m | not reported | not reported | [47.5](/filings/0001171843-18-002347.md) | [66.8](/filings/0001171843-19-001741.md) | [73.9](/filings/0001171843-20-002057.md) | [74.1](/filings/0001171843-21-002114.md) | [76.4](/filings/0001171843-22-002985.md) | [87.2](/filings/0001171843-23-002634.md) | [78.1](/filings/0001171843-24-002288.md) | [12.7](/filings/0001171843-25-002591.md) | [11.8](/filings/0001171843-26-001802.md) | [6.7](/filings/0001171843-26-001802.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [1.1](/filings/0001171843-20-002057.md) | [0.9](/filings/0001171843-21-002114.md) | [0.6](/filings/0001171843-22-002985.md) | [0.6](/filings/0001171843-23-002634.md) | [0.4](/filings/0001171843-24-002288.md) | [1.0](/filings/0001171843-25-002591.md) | [0.5](/filings/0001171843-26-001802.md) | [0.6](/filings/0001171843-26-001802.md) |
| Total liabilities | $m | not reported | not reported | [2.3](/filings/0001171843-18-002347.md) | [2.1](/filings/0001171843-19-001741.md) | [2.6](/filings/0001171843-20-002057.md) | [5.5](/filings/0001171843-21-002114.md) | [5.3](/filings/0001171843-22-002985.md) | [7.0](/filings/0001171843-23-002634.md) | [8.2](/filings/0001171843-24-002288.md) | [6.9](/filings/0001171843-25-002591.md) | [8.8](/filings/0001171843-26-001802.md) | [0.6](/filings/0001171843-26-001802.md) |
| Shareholders' equity | $m | [39.6](/filings/0001171843-18-002347.md) | [36.0](/filings/0001171843-19-001741.md) | [45.2](/filings/0001171843-20-002057.md) | [64.7](/filings/0001171843-21-002114.md) | [71.4](/filings/0001171843-22-002985.md) | [68.6](/filings/0001171843-23-002634.md) | [71.2](/filings/0001171843-24-002288.md) | [79.5](/filings/0001171843-25-002591.md) | [69.2](/filings/0001171843-26-001802.md) | [5.8](/filings/0001171843-26-001802.md) | [3.0](/filings/0001171843-26-001802.md) | [6.1](/filings/0001171843-26-001802.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 137,363,181 at 2025-12-31, from the cover of the [20-F filed 2026-03-19](/filings/0001171843-26-001802.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.